The trace amine b-phenylethylamine (PEA) is normally present in the body at low nanomolar concentrations but can reach micromolar levels after ingestion of drugs that inhibit monoamine oxidase and primary amine oxidase. In vivo, PEA elicits a robust pressor response, but there is no consensus regarding the underlying mechanism, with both vasodilation and constriction reported in isolated blood vessels. Using functional and biochemical approaches, we found that at low micromolar concentrations PEA (1-30 mM) enhanced nerve-evoked vasoconstriction in the perfused rat mesenteric bed but at a higher concentration (100 mM) significantly inhibited these responses. The a 2 -adrenoceptor antagonist rauwolscine (1 mM) also enhanced nerve-mediated vasoconstriction, but in the presence of both rauwolscine (1 mM) and PEA (30 mM) together, nerveevoked responses were initially potentiated and then showed time-dependent rundown. PEA (10 and 100 mM) significantly increased noradrenaline outflow from the mesenteric bed as determined by high-pressure liquid chromatography coupled with electrochemical detection. In isolated endothelium-denuded arterial segments, PEA (1 mM to 1 mM) caused concentrationdependent reversal of tone elicited by the a 1 -adrenoceptor agonists noradrenaline (EC 50 51.69 6 10.8 mM; n 5 5), methoxamine (EC 50 68.21 6 1.70 mM; n 5 5), and phenylephrine (EC 50 67.74 6 16.72 mM; n 5 5) but was ineffective against tone induced by prostaglandin F 2a or U46619 (9,11-dideoxy-9a,11a-methanoepoxyprostaglandin F 2a H]rauwolscine (K i % 1.2 mM), ligands for a 1 -and a 2 -adrenoceptors, respectively. These data provide the first demonstration that dual indirect sympathomimetic and a 1 -adrenoceptor blocking actions underlie the vascular effects of PEA in resistance arteries.